
Ceryx Builds First Implantable Heart Failure Device
Ceryx Medical has manufactured its first implantable heart failure device at King's College London's MAISI facility, with further testing ahead.
Explore the latest biotech and health technology news, from medical devices and healthcare AI to genetics, synthetic biology and scientific research. TechAmerica.ai covers medical robotics, digital health, clinical trials, biotech startups, drug development, breakthrough therapies and investment trends shaping healthcare innovation around the world.
62 articles · page 2 of 6 · showing 13 to 24

Ceryx Medical has manufactured its first implantable heart failure device at King's College London's MAISI facility, with further testing ahead.

Edwards Lifesciences received FDA approval for PASCAL Precision tricuspid valve repair in eligible patients with symptomatic severe tricuspid regurgitation.

Oura has filed another patent-infringement lawsuit against Ultrahuman, seeking damages and a permanent ban on sales of the redesigned Ring Pro in the US. Ultrahuman says no court order…

Baba has raised $40 million in Series A funding to expand its AI healthcare navigation platform, clinical care teams, AI research and health plan partnerships.

Intuitive's U.S. da Vinci procedure growth slowed to 10% in the third quarter, while system placements and worldwide procedure volumes continued to increase.

The FDA is preparing draft guidance on generative AI medical devices after receiving more than 500 submissions, with the policy work now a priority at the highest levels of the…

EndoQuest Robotics has hired Jared Eben as chief commercial officer as the company prepares for the potential U.S. launch of its flexible robotic surgery system.

ARPA-H is committing up to $117.4 million to four biosensor projects targeting heart failure, inflammation and perimenopause.

Medical Microinstruments has raised $125 million to expand its Symani robotic microsurgery system and fund additional clinical research.

Abbott’s CardioMEMS system gets FDA approval for new features that let patients view pressure readings and receive treatment updates on a smartphone.

Healthleap raised $38 million to expand its AI platform that analyses hospital records and flags patients who may need further clinical review.

The FDA is prioritising guidance on AI medical devices, generative AI and robotically assisted surgical systems for fiscal 2027.